These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 35586615)

  • 1. Migration of Hospital Total Hip and Knee Arthroplasty Procedures to an Ambulatory Surgery Center Setting and Postsurgical Opioid Use: A Private Practice Experience.
    Van Horne J; Van Horne A; Liao N; Romo-LeTourneau V
    Am Health Drug Benefits; 2022 Mar; 15(1):21-29. PubMed ID: 35586615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of treatment with liposomal bupivacaine on hospital costs, length of stay, and discharge status in patients undergoing total knee arthroplasty at high-use institutions.
    Asche CV; Dagenais S; Kang A; Ren J; Maurer BT
    J Med Econ; 2019 Jan; 22(1):85-94. PubMed ID: 30378454
    [No Abstract]   [Full Text] [Related]  

  • 3. Can Multimodal Pain Management in TKA Eliminate Patient-controlled Analgesia and Femoral Nerve Blocks?
    Yu S; Dundon J; Solovyova O; Bosco J; Iorio R
    Clin Orthop Relat Res; 2018 Jan; 476(1):101-109. PubMed ID: 29529623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal bupivacaine reduces opioid consumption and length of stay in patients undergoing primary total hip arthroplasty.
    VanWagner MJ; Krebs NM; Corser W; Johnson CN
    Hip Int; 2019 May; 29(3):276-281. PubMed ID: 29808726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal Bupivacaine Infiltration Versus Bupivacaine Hydrochloride for the Management of Unilateral Total Knee Arthroplasty in Geriatric Patients at a 287-Bed Community Hospital.
    Minhaj AS; Skipper AM; Murphy M
    Hosp Pharm; 2021 Dec; 56(6):792-796. PubMed ID: 34732940
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of liposomal bupivacaine on opioid use, hospital length of stay, discharge status, and hospitalization costs in patients undergoing total hip arthroplasty.
    Asche CV; Dagenais S; Kang A; Ren J; Maurer BT
    J Med Econ; 2019 Dec; 22(12):1253-1260. PubMed ID: 31161837
    [No Abstract]   [Full Text] [Related]  

  • 7. Pain Control and Functional Milestones in Total Knee Arthroplasty: Liposomal Bupivacaine versus Femoral Nerve Block.
    Yu S; Szulc A; Walton S; Bosco J; Iorio R
    Clin Orthop Relat Res; 2017 Jan; 475(1):110-117. PubMed ID: 26883652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Liposomal Bupivacaine Infiltration on the Management of Total Knee Arthroplasty.
    Sakamoto B; Keiser S; Meldrum R; Harker G; Freese A
    JAMA Surg; 2017 Jan; 152(1):90-95. PubMed ID: 27732710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal Bupivacaine Suspension, Can Reduce Length of Stay and Improve Discharge Status of Patients Undergoing Total Hip Arthroplasty.
    Cherian JJ; Barrington J; Elmallah RK; Chughtai M; Mistry JB; Mont MA
    Surg Technol Int; 2015 Nov; 27():235-9. PubMed ID: 26680403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-optimizing enhanced recovery pathways for total knee and hip arthroplasty in Medicare patients: implication for transition to ambulatory surgery centers.
    Van Horne A; Van Horne J
    Arthroplast Today; 2019 Dec; 5(4):497-502. PubMed ID: 31886397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No Difference in Early Analgesia Between Liposomal Bupivacaine Injection and Intrathecal Morphine After TKA.
    Barrington JW; Emerson RH; Lovald ST; Lombardi AV; Berend KR
    Clin Orthop Relat Res; 2017 Jan; 475(1):94-105. PubMed ID: 27339124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local infiltration for postsurgical analgesia following total hip arthroplasty: a comparison of liposomal bupivacaine to traditional bupivacaine.
    Asche CV; Ren J; Kim M; Gordon K; McWhirter M; Kirkness CS; Maurer BT
    Curr Med Res Opin; 2017 Jul; 33(7):1283-1290. PubMed ID: 28375752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-benefit evaluation of liposomal bupivacaine in the management of patients undergoing total knee arthroplasty.
    Kirkness CS; Asche CV; Ren J; Kim M; Rainville EC
    Am J Health Syst Pharm; 2016 May; 73(9):e247-54. PubMed ID: 27099332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Neuraxial Anesthesia Protocols and Improved Efficiency of Same-Day Discharge Total Knee Arthroplasty in an Ambulatory Surgery Center: A Retrospective Cohort Study.
    Calkins TE; Wing CC; Diltz ZR; Mihalko WM; Toy PC
    J Am Acad Orthop Surg; 2023 Mar; 31(5):e256-e263. PubMed ID: 36821081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discontinuation of the liposomal delivery of bupivacaine has no effect on pain management after primary total knee arthroplasty : no effect on pain scores, opioid consumption, or functional status.
    Feng JE; Ikwuazom CP; Mahure SA; Waren DP; Slover JD; Schwarzkopf RS; Long WJ; Macaulay WB
    Bone Joint J; 2021 Jun; 103-B(6 Supple A):102-107. PubMed ID: 34053282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Learning Curve Associated with the Administration of Intra-Articular Liposomal Bupivacaine for Total Knee Arthroplasty: A Pilot Study.
    Khlopas A; Elmallah RK; Chughtai M; Yakubek GA; Faour M; Klika AK; Higuera CA; Molloy RM; Mont MA
    Surg Technol Int; 2017 Feb; 30():314-320. PubMed ID: 28182826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Efficacy of Liposomal Bupivacaine Using Periarticular Injection in Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.
    Kuang MJ; Du Y; Ma JX; He W; Fu L; Ma XL
    J Arthroplasty; 2017 Apr; 32(4):1395-1402. PubMed ID: 28082044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Three-arm Randomized Clinical Trial Comparing Continuous Femoral Plus Single-injection Sciatic Peripheral Nerve Blocks versus Periarticular Injection with Ropivacaine or Liposomal Bupivacaine for Patients Undergoing Total Knee Arthroplasty.
    Amundson AW; Johnson RL; Abdel MP; Mantilla CB; Panchamia JK; Taunton MJ; Kralovec ME; Hebl JR; Schroeder DR; Pagnano MW; Kopp SL
    Anesthesiology; 2017 Jun; 126(6):1139-1150. PubMed ID: 28234636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal Bupivacaine Suspension Can Reduce Lengths of Stay and Improve Discharge Status of Patients Undergoing Total Knee Arthroplasty.
    Chughtai M; Cherian JJ; Mistry JB; Elmallah RD; Bennett A; Mont MA
    J Knee Surg; 2016 Apr; 29(3):224-7. PubMed ID: 26838971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized, Multicenter, Double-Blind Study of Local Infiltration Analgesia with Liposomal Bupivacaine for Postsurgical Pain Following Total Knee Arthroplasty: Rationale and Design of the Pillar Trial.
    Dysart S; Snyder MA; Mont MA
    Surg Technol Int; 2016 Nov; 30():261-267. PubMed ID: 27824434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.